Ingalls & Snyder LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,472	Closed	-$277K	–	426
2020 Q4	$277K	Buy	4,472 +833	+23%	+$51.6K	0.01%	345
2020 Q3	$216K	Buy	+3,639	New	+$216K	0.01%	330